{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:33Z","timestamp":1791295353714,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.beha.2005.07.002","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T13:25:13Z","timestamp":1150377913000},"page":"399-412","source":"Crossref","is-referenced-by-count":12,"title":["Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models"],"prefix":"10.1016","volume":"19","author":[{"given":"Hedia","family":"Chagraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.07.002_bib1","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","article-title":"Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines","volume":"17","author":"Barosi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.07.002_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0369-8114(00)00023-7","article-title":"Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis","volume":"49","author":"Kutti","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.beha.2005.07.002_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.07.002_bib4","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood.V96.10.3374","article-title":"Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia","volume":"96","author":"Mesa","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","article-title":"The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia","volume":"104","author":"Barosi","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.07.002_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2005.07.002_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.beha.2005.07.002_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycethemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2005.07.002_bib9","doi-asserted-by":"crossref","unstructured":"Kralovics R, Passamonti F, Buser AS. A gain of function mutation in Jak2 is frequently found in patients with myeloproliferative disorders. N Engl J Med 2005; 352: 1779\u20131190.","DOI":"10.1056\/NEJMoa051113"},{"key":"10.1016\/j.beha.2005.07.002_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s002770050595","article-title":"Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis","volume":"78","author":"Le Bousse-Kerdiles","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2005.07.002_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-2964(80)90106-1","article-title":"Study of a virus-induced myeloproliferative syndrome associated with tumor formation in mice","volume":"16","author":"Le Bousse-Kerdiles","year":"1980","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beha.2005.07.002_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI8902","article-title":"Fatal myeloproliferation, induced in mice by TEL\/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579\/581","volume":"105","author":"Tomasson","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2005.07.002_bib13","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1084\/jem.20011883","article-title":"Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice","volume":"195","author":"Velazquez","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2005.07.002_bib14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.1605.1605","article-title":"Transgenic expression of Bach1 transcription factor results in megakaryocytic impairment","author":"Toki","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.183.2.651","article-title":"Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin","volume":"183","author":"de Sauvage","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2005.07.002_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1642732","article-title":"Thrombopoietin: the primary regulator of megakaryocyte and platelet production","volume":"74","author":"Kaushansky","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2005.07.002_bib17","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V87.6.2162.bloodjournal8762162","article-title":"Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl","volume":"87","author":"Alexander","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V88.3.803.803","article-title":"Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice","volume":"88","author":"Carver-Moore","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood.V92.1.4.413k38_4_10","article-title":"Role of c-mpl in early hematopoiesis","volume":"92","author":"Solar","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib20","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V88.7.2578.bloodjournal8872578","article-title":"Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis","volume":"88","author":"Cohen-Solal","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib21","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V87.6.2154.bloodjournal8762154","article-title":"Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets","volume":"87","author":"Fielder","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib22","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood.V87.12.5006.bloodjournal87125006","article-title":"Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice","volume":"87","author":"Ulich","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.gt.3300638","article-title":"Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression","volume":"5","author":"Abina","year":"1998","journal-title":"Gene Ther"},{"key":"10.1016\/j.beha.2005.07.002_bib24","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1182\/blood.V90.11.4369","article-title":"High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice","volume":"90","author":"Villeval","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V89.5.1551","article-title":"Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment","volume":"89","author":"Zhou","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4049\/jimmunol.160.2.691","article-title":"Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis","volume":"160","author":"Frey","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2005.07.002_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood.V88.3.778.778","article-title":"In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression","volume":"88","author":"Ohwada","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nbt0697-570","article-title":"Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA","volume":"15","author":"Cannizzo","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.beha.2005.07.002_bib29","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.160.9.4481","article-title":"Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO","volume":"160","author":"Abina","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2005.07.002_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood.V88.2.402.bloodjournal882402","article-title":"A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation","volume":"88","author":"Yan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib31","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1182\/blood.V86.11.4025.bloodjournal86114025","article-title":"Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice","volume":"86","author":"Yan","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib32","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V96.4.1342","article-title":"Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis","volume":"96","author":"Schmitt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2002-06-1913","article-title":"Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice)","volume":"100","author":"Vannucchi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0959-437X(00)00226-4","article-title":"Hematopoietic development: a balancing act","volume":"11","author":"Cantor","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.beha.2005.07.002_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1242\/dev.121.1.163","article-title":"Development of hematopoietic cells lacking transcription factor GATA-1","volume":"121","author":"Pevny","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.beha.2005.07.002_bib36","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1093\/emboj\/16.13.3965","article-title":"A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development","volume":"16","author":"Shivdasani","year":"1997","journal-title":"Embo J"},{"key":"10.1016\/j.beha.2005.07.002_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V98.1.85","article-title":"Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation","volume":"98","author":"Freson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/73480","article-title":"Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1","volume":"24","author":"Nichols","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2005.07.002_bib39","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood.V93.9.2867","article-title":"Consequences of GATA-1 deficiency in megakaryocytes and platelets","volume":"93","author":"Vyas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2002-06-1856","article-title":"An animal model for myelofibrosis","volume":"100","author":"Shivdasani","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib41","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood-2004-04-1320","article-title":"A patho-biological pathway linking thrombopoietin, GATA-1 and TGF-{beta}1 in the development of myelofibrosis","volume":"105","author":"Vannucchi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<133::AID-AJH6>3.0.CO;2-Z","article-title":"Systemic transforming growth factor-beta in patients with bone marrow fibrosis\u2014pathophysiological implications","volume":"59","author":"Rameshwar","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2005.07.002_bib43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0369-8114(00)00021-3","article-title":"Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis","volume":"49","author":"Le Bousse-Kerdiles","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.beha.2005.07.002_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2141.1997.292671.x","article-title":"Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis","volume":"97","author":"Martyre","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.07.002_bib45","first-page":"427","article-title":"Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components","volume":"154","author":"Castro-Malaspina","year":"1984","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.beha.2005.07.002_bib46","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.V96.6.2022","article-title":"Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis","volume":"96","author":"Fortunel","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.1989.tb04310.x","article-title":"Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts","volume":"72","author":"Kimura","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.07.002_bib48","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1073\/pnas.83.12.4167","article-title":"Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro","volume":"83","author":"Roberts","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2005.07.002_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1994.tb04970.x","article-title":"Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis","volume":"88","author":"Martyre","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.07.002_bib50","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V75.7.1540.1540","article-title":"The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis","volume":"75","author":"Terui","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.07.002_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI19540","article-title":"TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia","volume":"113","author":"Shehata","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2005.07.002_bib53","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-04-1133","article-title":"Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice","volume":"100","author":"Chagraoui","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib54","first-page":"264","article-title":"Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders","volume":"146","author":"Kulkarni","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2005.07.002_bib55","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.beha.2005.07.002_bib56","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","article-title":"The osteoblast: a sophisticated fibroblast under central surveillance","volume":"289","author":"Ducy","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.beha.2005.07.002_bib57","first-page":"27","article-title":"Transforming growth factor-beta gene family members and bone","volume":"15","author":"Centrella","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beha.2005.07.002_bib58","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","article-title":"TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation","volume":"20","author":"Alliston","year":"2001","journal-title":"Embo J"},{"key":"10.1016\/j.beha.2005.07.002_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.beha.2005.07.002_bib60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.beha.2005.07.002_bib61","doi-asserted-by":"crossref","first-page":"27091","DOI":"10.1074\/jbc.273.42.27091","article-title":"Transforming growth factor-beta stimulates the production of osteoprotegerin\/osteoclastogenesis inhibitory factor by bone marrow stromal cells","volume":"273","author":"Takai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beha.2005.07.002_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.0.1410195","article-title":"Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism","volume":"141","author":"Hofbauer","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beha.2005.07.002_bib63","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2002-09-2839","article-title":"Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO","volume":"101","author":"Chagraoui","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1359\/JBMR.0301254","article-title":"Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2","volume":"19","author":"Kacena","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.beha.2005.07.002_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2141.1981.tb02693.x","article-title":"On the alleged phagocytosis by megakaryocytes","volume":"47","author":"Breton-Gorius","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.07.002_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01695470","article-title":"The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states","volume":"64","author":"Cashell","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2005.07.002_bib67","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1182\/blood-2004-01-0193","article-title":"Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice","volume":"104","author":"Centurione","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib68","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V93.3.876","article-title":"Platelet\/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b\/CD18 adhesion: role of PSGL-1 as a signaling molecule","volume":"93","author":"Evangelista","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood.V93.1.125","article-title":"Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L","volume":"93","author":"Taksin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib70","first-page":"2457","article-title":"Reduced GATA-1 content in megakaryocytes of patients with idiopathic myelofibrosis","volume":"102","author":"Vannucchi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.002_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428199509054751","article-title":"TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders","volume":"20","author":"Martyre","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2005.07.002_bib72","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.exphem.2004.07.006","article-title":"Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG)","volume":"32","author":"Wang","year":"2004","journal-title":"Exp Hematol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T18:58:34Z","timestamp":1683485914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1521692605000885"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.07.002","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}